Investors Seek Growth Stocks Backed by Insider Ownership

European markets are trading mixed, with the STOXX Europe 600 pulling back and ECB rate expectations steady, prompting investors to focus on small-cap and growth stocks where strong fundamentals and insider buying or high insider ownership can signal confidence (screeners highlighted 62 undervalued small caps, 191 fast-growing European names and 619 Asian names). Volex is singled out as an undervalued small-cap with forecasted earnings growth of about 14% annually, recent insider purchases, guidance for H1 2025 revenue above $575m and an expected 9–10% operating margin despite reliance on external borrowing. Nordic CRM provider Lime Technologies is flagged for above-market earnings growth (forecast ~22% annually) and high insider ownership, while Kuros Biosciences has raised guidance and sees rapid revenue expansion; PharmaMar is noted as a fast-growing Spanish biopharma (earnings growth forecast ~58% annually) trading at a discount but with volatile shares. In Asia, ALTEOGEN shows very strong revenue and earnings growth forecasts and has won recent European approval for a biosimilar product. Smaller cases such as Legacy Minerals illustrate how clustered insider buying — including a AU$100,000 purchase by its non-executive chair — can be a favorable but not definitive signal for investors.